CVS HEALTH CORPORATION Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss
CVS HEALTH CORPORATION (CVS) had Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss of $422.00 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss · last filed 2026-08-05
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $422.00M.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $447.00M.
- 2025-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $331.00M.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $332.00M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss |
|---|---|
| 2026-06-30 | $422.00M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $447.00M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $331.00M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $332.00M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $449.00M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $547.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $707.00M 10-K · filed 2026-02-10 |
| 2024-09-30 | $453.00M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $863.00M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $873.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $836.00M 10-K · filed 2025-02-12 |
| 2023-09-30 | $1.74B 10-Q · filed 2023-11-01 |
| 2023-06-30 | $1.43B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $1.39B 10-Q · filed 2023-05-03 |
| 2022-12-31 | $1.84B 10-K · filed 2024-02-07 |
| 2022-09-30 | $2.23B 10-Q · filed 2022-11-02 |
| 2022-06-30 | $1.51B 10-Q · filed 2022-08-03 |
| 2022-03-31 | $726.00M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $106.00M 8-K · filed 2023-05-25 |
| 2021-09-30 | $55.00M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $32.00M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $75.00M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $11.00M 10-K · filed 2022-02-09 |
| 2020-09-30 | $38.00M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $53.00M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $246.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $11.00M 10-K · filed 2021-02-16 |
| 2019-09-30 | $13.00M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $7.00M 10-Q · filed 2019-08-07 |
| 2018-12-31 | $36.00M 10-K · filed 2020-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |